mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
0.083 |
0.6 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |